Regulus files for IPO

MicroRNA company Regulus Therapeutics Inc. (San Diego, Calif.) capped off a newsy week by filing late Friday to raise up to $57.5 million in an IPO underwritten by Lazard; Cowen; BMO Capital Markets; Needham; and Wedbush PacGrow. Earlier this week, Regulus announced two separate microRNA deals with AstraZeneca plc (LSE:AZN; NYSE:AZN) and Biogen Idec Inc. (NASDAQ:BIIB). ...